Amazing result of Nivolumab in a patient with multiple carcinoma

J BUON. 2019 Mar-Apr;24(2):865-867.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / classification*
  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / immunology
  • Aged
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Female
  • Humans
  • Neoplasms / classification*
  • Neoplasms / drug therapy*
  • Neoplasms / immunology
  • Nivolumab / therapeutic use*
  • Prognosis
  • Remission Induction

Substances

  • Antineoplastic Agents, Immunological
  • Nivolumab